Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HIF‐1 at the crossroads of hypoxia, inflammation, and cancer
Kuppusamy Balamurugan
International Journal of Cancer (2015) Vol. 138, Iss. 5, pp. 1058-1066
Open Access | Times Cited: 493

Showing 1-25 of 493 citing articles:

Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?
Natalia Prevarskaya, Roman Skryma, Yaroslav Shuba
Physiological Reviews (2018) Vol. 98, Iss. 2, pp. 559-621
Open Access | Times Cited: 369
NF‐κB and HIF crosstalk in immune responses
Laura D’Ignazio, Daniel Bandarra, Sónia Rocha
FEBS Journal (2015) Vol. 283, Iss. 3, pp. 413-424
Open Access | Times Cited: 302
Impact of Metabolic Syndrome on Neuroinflammation and the Blood–Brain Barrier
Peter Van Dyken, Baptiste Lacoste
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 284
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Qinghua Wu, You Li, Eugenie Nepovimová, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 271
Xanthine Oxidoreductase‐Derived Reactive Species: Physiological and Pathological Effects
Maria Giulia Battelli, Letizia Polito, Massimo Bortolotti, et al.
Oxidative Medicine and Cellular Longevity (2015) Vol. 2016, Iss. 1
Open Access | Times Cited: 257
HIF-1 in cancer therapy: two decade long story of a transcription factor
Sourabh Soni, Yogendra Padwad
Acta Oncologica (2017) Vol. 56, Iss. 4, pp. 503-515
Open Access | Times Cited: 234
Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
Qin Wu, Lingyun Zhou, Duoduo Lv, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 229
Reactive oxygen species and cancer: A complex interaction
Sankaralingam Saikolappan, Binod Kumar, Gauri Shishodia, et al.
Cancer Letters (2019) Vol. 452, pp. 132-143
Closed Access | Times Cited: 215
The role of hypoxia‐inducible factor 1 in tumor immune evasion
You Li, Wenda Wu, Xu Wang, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1622-1643
Closed Access | Times Cited: 212
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
Roger M. Phillips
Cancer Chemotherapy and Pharmacology (2016) Vol. 77, Iss. 3, pp. 441-457
Open Access | Times Cited: 211
Up-down regulation of HIF-1α in cancer progression
Mohsen Rashid, Leila Rostami Zadeh, Behzad Baradaran, et al.
Gene (2021) Vol. 798, pp. 145796-145796
Closed Access | Times Cited: 189
The Role of Cancer Stem Cells in Radiation Resistance
C. Arnold, Julian Mangesius, Ira Skvortsova, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 188
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy
Tianchi Yu, Bo Tang, Xueying Sun
Yonsei Medical Journal (2017) Vol. 58, Iss. 3, pp. 489-489
Open Access | Times Cited: 179
The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy
Zhe Ge, Shuzhe Ding
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 172
Fibronectin in Cancer: Friend or Foe
Tsung-Cheng Lin, Cheng-Han Yang, Li-Hsin Cheng, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 27-27
Open Access | Times Cited: 167
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
Jenna L. Carter, Katie Hege, Jay Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 166
Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis
Kritika Saxena, Mohit Kumar Jolly, Kuppusamy Balamurugan
Translational Oncology (2020) Vol. 13, Iss. 11, pp. 100845-100845
Open Access | Times Cited: 164
Cancer drug resistance induced by EMT: novel therapeutic strategies
Javier De Las Rivas, Anamaria Brozović, Sivan Izraely, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 7, pp. 2279-2297
Open Access | Times Cited: 149
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
Muhlis Akman, Dimas Carolina Belisario, Iris C. Salaroglio, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 124
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
Tetiana Hourani, James A. Holden, Wenyi Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 116
Factors Influencing Gallstone Formation: A Review of the Literature
Hao Sun, Jonathan R. Warren, James Yip, et al.
Biomolecules (2022) Vol. 12, Iss. 4, pp. 550-550
Open Access | Times Cited: 110
The Roles of 2-Hydroxyglutarate
Xin Du, Hai Hu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 107
The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment
Daoying Zhou, Zhen Duan, Zhenyu Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 89
Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10
Rui Yang, Hang Chen, Lei Xing, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 81
Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain
Bich Phuong Bui, Phuong Linh Nguyen, Kyeong Lee, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6054-6054
Open Access | Times Cited: 81
Page 1 - Next Page

Scroll to top